Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.454 CHF
78.37 M CHF
548.46 M CHF
3.63 M
About YPSOMED HLDG
Sector
Industry
CEO
Simon Michel
Website
Headquarters
Burgdorf
Founded
2003
ISIN
CH0019396990
FIGI
BBG006M6Z1Q9
Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. It operates through the following segments: Ypsomed Diabetes Care, Ypsomed Delivery Systems, and Others. The Ypsomed Diabetes Care segment is involved in the products that are sold directly to hospitals, doctors, pharmacies, and patients via Ypsomed subsidiaries and distributors. The Ypsomed Delivery Systems segment focuses on the pharmaceutical and biotech customers with injection systems and related services. The Others segment consists of Ypsotec and properties not used for operational purposes. The company was founded by Wilhelm Michel on December 29, 2003, and is headquartered in Burgdorf, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OWX is 343.058 CHF — it has decreased by −0.87% in the past 24 hours. Watch YPSOMED HOLDING AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange YPSOMED HOLDING AG stocks are traded under the ticker OWX.
OWX stock has fallen by −11.40% compared to the previous week, the month change is a −16.25% fall, over the last year YPSOMED HOLDING AG has showed a 17.00% increase.
We've gathered analysts' opinions on YPSOMED HOLDING AG future price: according to them, OWX price has a max estimate of 495.00 CHF and a min estimate of 326.00 CHF. Watch OWX chart and read a more detailed YPSOMED HOLDING AG stock forecast: see what analysts think of YPSOMED HOLDING AG and suggest that you do with its stocks.
OWX stock is 0.94% volatile and has beta coefficient of 0.12. Track YPSOMED HOLDING AG stock price on the chart and check out the list of the most volatile stocks — is YPSOMED HOLDING AG there?
Today YPSOMED HOLDING AG has the market capitalization of 4.76 B, it has decreased by −1.10% over the last week.
Yes, you can track YPSOMED HOLDING AG financials in yearly and quarterly reports right on TradingView.
YPSOMED HOLDING AG is going to release the next earnings report on May 21, 2025. Keep track of upcoming events with our Earnings Calendar.
YPSOMED HOLDING AG revenue for the last half-year amounts to 324.00 M CHF, despite the estimated figure of 298.65 M CHF. In the next half-year revenue is expected to reach 349.20 M CHF.
OWX net income for the last half-year is 32.60 M CHF, while the previous report showed 41.79 M CHF of net income which accounts for −21.99% change. Track more YPSOMED HOLDING AG financial stats to get the full picture.
YPSOMED HOLDING AG dividend yield was 0.55% in 2023, and payout ratio reached 34.83%. The year before the numbers were 0.68% and 34.02% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 2.30 K employees. See our rating of the largest employees — is YPSOMED HOLDING AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. YPSOMED HOLDING AG EBITDA is 178.76 M CHF, and current EBITDA margin is 28.43%. See more stats in YPSOMED HOLDING AG financial statements.
Like other stocks, OWX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade YPSOMED HOLDING AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So YPSOMED HOLDING AG technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating YPSOMED HOLDING AG stock shows the neutral signal. See more of YPSOMED HOLDING AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.